CLINICAL_TRIALS
research
· 2026-03-03
Clinical Trial Update: RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma [Phase 4]
Summary
Clinical trial update showing Phase 4 study of tunlametinib in NRAS-mutant advanced melanoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fudan University | Conditions: Melanoma Advanced | Phase 4 | Status: RECRUITING